| INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA REC Patent applications |
| Patent application number | Title | Published |
|---|
| 20110059856 | IN VITRO DIAGNOSTIC METHOD FOR THE DIAGNOSIS OF SOMATIC AND OVARIAN CANCERS - Method of using one element chosen among a nucleic acid molecule, a fragment of the nucleic acid molecule and a variant of the nucleic acid molecule for the in vitro or ex vivo diagnosis of any type of somatic or ovarian cancers, wherein at least one of any of the above described elements is abnormally expressed in cancer cells of at least one type of the somatic or ovarian cancers, and wherein each type of somatic or ovarian cancer cells abnormally expresses at least one of the above described elements. | 03-10-2011 |
| 20100267646 | Trophic Factor for the Treatment of Retinal Degenerative Diseases - This invention relates to methods and compositions for detection and treatment of retinal degenerative diseases. In particular, the invention relates to polypeptides that can protect against cone degeneration, nucleic acid molecules that encode such polypeptides, and antibodies that recognize said polypeptides. | 10-21-2010 |
| 20100247520 | MUTATED NETRIN 4, FRAGMENTS THEREOF AND USES THEREOF AS DRUGS - The present invention relates to a protein comprising or consisting of one of the following sequences: the sequence SEQ ID NO: 2 or SEQ ID NO: 4, or a fragment of said sequence represented by one of the sequences SEQ ID NO: 2 | 09-30-2010 |
| 20100179066 | Method for Assessing the Risk of a Cardiovascular Disease and for Diagnosing Dyslipidemia - The invention relates to a method for assessing the risk of a cardiovascular disease and/or for diagnosing dyslipidemia in a patient, said method comprising: a) isolating in a blood sample obtained from said patient the high density lipoprotein (HDL) fraction or a subfraction thereof; and b) measuring in said HDL fraction or subfraction thereof the concentration of one or more biomarkers selected from the group consisting of Sphingosine-1-Phosphate (S1P), sphingomyelin (SM) and Apolipoprotein A-I (apoA-1). | 07-15-2010 |
| 20090292021 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS - Pharmaceutical compositions including, as the active ingredients, a combination of vigabatrin and of at least one substance having anti-ischemic effect, are disclosed. | 11-26-2009 |
